Hope for the Treatment of Kidney Fibrosis
Chronic Kidney Disease (CKD) is a condition in which the kidneys are damaged or cannot filter blood as well as healthy kidneys, often as a result of fibrosis. Grey Matters Health is in the early planning stages of its clinical program researching NP-251 (Repirinast) as a potential treatment for kidney inflammation and fibrosis through its wholly owned NASH Pharmaceuticals subsidiary.
